1
项与 Anti-BCMA CAR-T (Actavis Group hf) 相关的临床试验A Phase 1b Clinical Trial of Anti-BCMA Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Multiple Myeloma
This is an open-label study to determine the safety of anti-B-cell maturation antigen (BCMA) Chimeric antigen receptor T-cell (CAR T) therapy in participants with Relapsed or Refractory Multiple Myeloma (RRMM).
100 项与 Anti-BCMA CAR-T (Actavis Group hf) 相关的临床结果
100 项与 Anti-BCMA CAR-T (Actavis Group hf) 相关的转化医学
100 项与 Anti-BCMA CAR-T (Actavis Group hf) 相关的专利(医药)
100 项与 Anti-BCMA CAR-T (Actavis Group hf) 相关的药物交易